Literature DB >> 5793698

Failure of potent antacid therapy to hasten healing in chronic gastric ulcers.

P E Baume, J H Hunt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5793698     DOI: 10.1111/imj.1969.18.2.113

Source DB:  PubMed          Journal:  Australas Ann Med        ISSN: 0571-9283


× No keyword cloud information.
  15 in total

1.  Antacid vs placebo in hospitalized gastric ulcer patients: a controlled therapeutic study.

Authors:  M L Butler; H Gersh
Journal:  Am J Dig Dis       Date:  1975-09

Review 2.  Drugs in the treatment of gastric and duodenal ulcer.

Authors:  M J Langman
Journal:  Drugs       Date:  1977-08       Impact factor: 9.546

3.  Management of chronic peptic ulcer and its complications.

Authors:  D W Piper; V H Cumberland; D I Fevre
Journal:  Drugs       Date:  1975       Impact factor: 9.546

Review 4.  Antacids and bleeding prophylaxis.

Authors:  T D McCaffrey; J Lilly
Journal:  Am J Dig Dis       Date:  1976-02

Review 5.  Medical management of peptic ulcer with reference to anti-ulcer agents in other gastro-intestinal diseases.

Authors:  D W Piper; T R Heap
Journal:  Drugs       Date:  1972       Impact factor: 9.546

6.  Letter: Drugs for gastric ulceration.

Authors:  A B Mitchell
Journal:  Br Med J       Date:  1974-06-01

Review 7.  Gastroenterology in Australia, 1949-69.

Authors:  S Goulston; K Breen
Journal:  Postgrad Med J       Date:  1970-04       Impact factor: 2.401

8.  Anti-ulcer therapy. Past to present.

Authors:  A Bettarello
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

9.  Medical treatment of gastric and duodenal ulcer.

Authors:  J H Baron
Journal:  Klin Wochenschr       Date:  1976-10-01

Review 10.  Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; R Spencer; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.